» Articles » PMID: 38103065

Exploring Systemic Inflammation in Children with Chronic Kidney Disease: Correlates of Interleukin 6

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2023 Dec 16
PMID 38103065
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic inflammation (SI) is linked to chronic kidney disease (CKD) progression and multiple complications. Data regarding SI biomarkers in pediatric patients are scarce. This case-control and cross-sectional study investigates the correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), total iron binding capacity (TIBC) and serum albumin to serum interleukin-6 (IL-6).

Methods: NLR and PLR were measured in 53 patients (median age: 12.9 years), including 17 on dialysis and 36 with a median glomerular filtration rate of 39 ml/min/1.73m, and in 25 age and sex-matched healthy controls. Iron profile, serum albumin and IL-6 were measured in the patient group. IL-6 levels > 3 quartile were classified as high.

Results: Patients presented higher NLR and PLR and particularly those on dialysis (p < 0.001 and p = 0.001). We observed a significant correlation between natural logarithm (ln) of IL-6 (lnIL-6) and NLR (rs = 0.344, p = 0.014), serum albumin (rs = -0.350, p = 0.011) and TIBC (rs = -0.345, p = 0.012) after adjustment for CKD stage, while the correlation between lnIL-6 and PLR was not significant (rs = 0.206, p = 0.151). Combination of NLR, serum albumin and TIBC predicted high IL-6 (13 patients) with an AUC of 0.771 (95% CI 0.608-0.943). Pairing of NLR ≥ 1.7 and TIBC ≤ 300 μg/dL exhibited the highest sensitivity (76.9%), while incorporating serum albumin ≤ 3.8 g/dL along with them achieved the highest specificity (95%) for detecting high IL-6 levels.

Conclusion: Both NLR and PLR levels increase in CKD, especially in patients on chronic dialysis. NLR, rather than PLR, along with TIBC and serum albumin, are associated with IL-6 in pediatric CKD.

Citing Articles

Neutrophil-to-lymphocyte ratio associated with renal function in type 2 diabetic patients.

Gao J, Shen J, Yang L, Liu L, Zhao K, Pan X World J Clin Cases. 2024; 12(14):2308-2315.

PMID: 38765748 PMC: 11099408. DOI: 10.12998/wjcc.v12.i14.2308.

References
1.
Akchurin O, Kaskel F . Update on inflammation in chronic kidney disease. Blood Purif. 2015; 39(1-3):84-92. DOI: 10.1159/000368940. View

2.
Cheung W, Paik K, Mak R . Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010; 25(4):711-24. DOI: 10.1007/s00467-009-1427-z. View

3.
Holle J, Querfeld U, Kirchner M, Anninos A, Okun J, Thurn-Valsassina D . Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease. Pediatr Nephrol. 2019; 34(12):2571-2582. DOI: 10.1007/s00467-019-04331-6. View

4.
Karava V, Kondou A, Dotis J, Christoforidis A, Taparkou A, Farmaki E . Association Between Adipokine Profile, Systemic Inflammation, Muscle and Protein Energy Wasting in Children With Chronic Kidney Disease. J Ren Nutr. 2023; 33(5):629-638. DOI: 10.1053/j.jrn.2023.05.002. View

5.
Akchurin O, Patino E, Dalal V, Meza K, Bhatia D, Brovender S . Interleukin-6 Contributes to the Development of Anemia in Juvenile CKD. Kidney Int Rep. 2019; 4(3):470-483. PMC: 6409399. DOI: 10.1016/j.ekir.2018.12.006. View